VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,397,000 | +28.3% | 60,115 | -12.2% | 0.03% | +35.0% |
| Q1 2018 | $1,089,000 | -36.8% | 68,430 | -17.5% | 0.02% | -31.0% |
| Q4 2017 | $1,723,000 | +164.7% | 82,930 | +120.5% | 0.03% | +141.7% |
| Q2 2017 | $651,000 | -77.2% | 37,609 | -85.4% | 0.01% | -76.9% |
| Q1 2017 | $2,850,000 | -80.7% | 258,360 | -54.1% | 0.05% | -71.7% |
| Q1 2016 | $14,794,000 | -0.3% | 562,306 | +653.6% | 0.18% | +145.3% |
| Q1 2015 | $14,843,000 | +30.6% | 74,614 | -6.0% | 0.08% | +41.5% |
| Q4 2014 | $11,362,000 | +4.7% | 79,401 | -4.1% | 0.05% | -15.9% |
| Q3 2014 | $10,848,000 | +37.3% | 82,757 | +32.1% | 0.06% | +57.5% |
| Q2 2014 | $7,903,000 | -7.3% | 62,667 | -3.1% | 0.04% | -11.1% |
| Q1 2014 | $8,529,000 | – | 64,642 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |